Search
Paroxetine
go.drugbank.com/drugs/DB00715ApprovedInvestigational[T653] It was approved by the FDA in the early 1990s and marketed by SmithKline Beecham. … It has a variety of uses, including the treatment of anxiety disorders, major depression, posttraumatic stress disorder, and symptoms of menopause, among others.
Products: PAROXETINA EG, PAROXETINA EG STADATorasemide
go.drugbank.com/drugs/DB00214ApprovedInvestigational[A174463] Structurally, it is a pyridine-sulfonylurea used as an antihypertensive agent.[A319] Torasemide was first approved for clinical use by the FDA in 1993.[L5257]
Categories: Increased Diuresis at Loop of HenleSynonyms: 1-Isopropyl-3-((4-m-toluidino-3-pyridyl)sulfonyl)ureaFluvoxamine
go.drugbank.com/drugs/DB00176ApprovedInvestigationalIt was launched in the US in December 1994 and in Japan in June 1999. As of the end of 1995, more than 10 million patients worldwide have been treated with fluvoxamine. … Though it is in the same class as other SSRI drugs, it is most often used to treat obsessive-compulsive disorder.
Products: FLUVOXAMINA EG, REVOXIN 100 MG FILM TABLET, 30 ADETIoversol
go.drugbank.com/drugs/DB09134ApprovedInvestigational[L41780] Iodine has a high atomic density, which gives it the ability to attenuate X-rays. … [L41780] Ioversol was approved by the FDA in 1989 and is currently indicated for computed tomographic (CT) imaging and contrast enhancement in peripheral arteriography, coronary arteriography, and left
International brands: OPTIRAY 320Products: Optiray 240 mg J/ml - (nichtionische) parenterale Röntgenkontrastmittellösung, Optiray 300 mg J/ml - (nichtionische) parenterale RöntgenkontrastmittellösungBuprenorphine
go.drugbank.com/drugs/DB00921ApprovedIllicitInvestigationalVet approved[A186263,A186266,A186269] Buprenorphine acts as a partial mu-opioid receptor agonist with a high affinity for the receptor, but lower intrinsic activity compared to other full mu-opioid agonists such … Buprenorphine is a weak partial mu-opioid receptor agonist and a weak kappa-opioid receptor antagonist used for the treatment of severe pain.
Mixtures: Suboxone 8 mg/2 mg sublingual tablets, Suboxone 2 mg/0.5 mg sublingual tabletsSynonyms: 2-(N-cyclopropylmethyl-4,5α-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6α-yl)-3,3-dimethyl-2-butanol, 17-cyclopropylmethyl-4,5α-epoxy-7α-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-olSitagliptin
go.drugbank.com/drugs/DB01261ApprovedInvestigationalSitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus[FDA label,A2260,A2255,A2256]. The effect of this medication ...
Mixtures: JANUMET 50 MG/500 MG FILM KAPLI TABLET, 56 ADET, JANUMET 50 MG/850 MG FILM KAPLI TABLET, 56 ADETProducts: SITAGLIPTIN EG, SIMEVI-STFlucloxacillin
go.drugbank.com/drugs/DB00301ApprovedInvestigationalWithdrawnAntibiotic analog of cloxacillin.
Synonyms: (2S,5R,6R)-6-({[3-(2-chloro-6-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolylpenicillinProducts: FLOKSIN 250 MG SURUP HAZIRLAMAK ICIN TOZ, 150 ML, Fluclox-125 Pws 125mg/5mlNaloxone
go.drugbank.com/drugs/DB01183ApprovedInvestigationalVet approvedNotably, if injected into a person not currently using opioid medications, there would be no noticeable effects at all. … [A234594] More specifically, naloxone has a high affinity for μ-opioid receptors, where it acts as an inverse agonist, causing the rapid removal of any other drugs bound to these receptors.
Mixtures: Targin 60 mg/30 mg Retardtabletten, Targin 20 mg/10 mg RetardtablettenSynonyms: 17-allyl-3,14-dihydroxy-4,5α-epoxymorphinan-6-oneCetuximab
go.drugbank.com/drugs/DB00002ApprovedInvestigational[A227963,L39045] It has also been investigated in advanced colorectal cancer, EGFR-expressing non-small cell lung cancer (NSCLC), and unresectable squamous cell skin cancer. … [A227973] EGFR is a member of the ErbB family of receptor tyrosine kinases found in both normal and tumour cells; it is responsible for regulating epithelial tissue development and homeostasis.
Products: ERBITUX 100 MG/20 ML IV INFUZYON ICIN COZELTI ICEREN FLAKON, 1 ADET, ERBITUX 500 MG/100 ML IV INFUZYON ICIN COZELTI ICEREN FLAKON, 1 ADETAllopurinol
go.drugbank.com/drugs/DB00437ApprovedInvestigationalIt was initially approved by the FDA in 1966 [L5674] and is now formulated by several manufacturers [L5677].
Products: ALLO - CT 100 MG TABLETTEN, ALLOPIN 300 MG TABLET, 50 ADET